Heron Neutron Medical Corp. (TPE:7799)
Taiwan · Delayed Price · Currency is TWD 357.00
-4.50 (-1.24%)
At close: Aug 6, 2026
Heron Neutron Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -479.38 | -481.67 | -260.08 | -126.39 | -86.18 |
Depreciation & Amortization | 44.98 | 39.51 | 20.03 | 14.07 | 12.55 |
Other Amortization | 0.1 | 0.12 | 0.57 | 1.31 | 1.41 |
Loss (Gain) From Sale of Assets | - | - | 7.05 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -0.49 | -1.31 |
Stock-Based Compensation | 150.65 | 161.83 | 22.55 | 2.32 | - |
Other Operating Activities | -6.39 | -2.97 | -0.64 | -0.29 | -0.01 |
Change in Accounts Receivable | - | -0.33 | - | - | - |
Change in Inventory | -246.47 | -60.97 | -6.37 | - | - |
Change in Accounts Payable | 19.67 | 13.03 | 0.22 | - | 2.97 |
Change in Other Net Operating Assets | -160.43 | -152.96 | -43.3 | -93.83 | -173.46 |
Operating Cash Flow | -677.6 | -484.4 | -259.97 | -54.57 | -62.05 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -40.56 | -27.81 | -42.22 | -56.19 | -111.1 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.57 |
Sale (Purchase) of Intangibles | -0.27 | -2.27 | - | - | -2.88 |
Investment in Securities | -9,661 | -8,734 | -100 | - | - |
Other Investing Activities | -347.37 | 2 | -6.76 | - | -0.24 |
Investing Cash Flow | -10,050 | -8,762 | -148.98 | -56.19 | -113.65 |
Long-Term Debt Repaid | - | -4.57 | -3.9 | -3.84 | -3.54 |
Net Debt Issued (Repaid) | -6.65 | -4.57 | -3.9 | -3.84 | -3.54 |
Issuance of Common Stock | 10,869 | 10,875 | 903.55 | 340 | 182 |
Financing Cash Flow | 10,862 | 10,871 | 899.65 | 336.16 | 178.46 |
Net Cash Flow | 135.57 | 1,625 | 490.7 | 225.4 | 2.77 |
Free Cash Flow | -718.16 | -512.21 | -302.19 | -110.76 | -173.14 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -6143.87% | -4969.02% | - | -46536.13% | - |
Free Cash Flow Per Share | -4.64 | -3.52 | -2.37 | -1.03 | -2.27 |
Levered Free Cash Flow | -611.75 | -375.66 | -199.96 | -134.13 | - |
Unlevered Free Cash Flow | -610.27 | -375.57 | -199.85 | -133.98 | - |
Cash Interest Paid | 2.36 | 0.14 | 0.18 | 0.24 | 0.28 |
Cash Income Tax Paid | 10.43 | 3.72 | 0.64 | 0.29 | 0.01 |
Change in Working Capital | -387.56 | -201.23 | -49.45 | 54.91 | 11.51 |